Delivery Order SPE2DB22D1202-SPE2DB25FVJH2
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,415.96 to AmerisourceBergen Drug Corp for Verquvo 5 mg tablets (14-count packaging) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order is unclassified and carries no set-aside designation, indicating competitive award status. The award leverages AmerisourceBergen's position as a major pharmaceutical distributor and represents a child order under the company's larger...
- The Defense Logistics Agency awarded a $1,243.00 delivery order to AmerisourceBergen Drug Corp for VERQUVO 10 mg tablets (30-count units) on April 22, 2025, with completion scheduled for April 23, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,851.91 to AmerisourceBergen Drug Corp for VERQUVO 2.5 mg tablets (30-count supply) on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a small-value pharmaceutical transaction within the company's broader federal contract portfolio. The award will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VERQUVO 10 mg tablets (30-count units) valued at $2,749.50 under a firm fixed-price contract type. The award was made on June 16, 2025, with an ultimate completion date of June 17, 2025. This delivery order is not set-aside and was competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. AmerisourceBergen Drug Corp serves as a critical vendor within the federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Verquvo 5 mg tablets (14-count units) with a ceiling value of $7,605.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Verquvo 10 mg tablets (quantity 90) at a firm fixed price of $12,569.21, with completion targeted for September 3, 2025. This contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $2,310.12 to AmerisourceBergen Drug Corp for VERQUVO 5 mg tablets (100-unit dose packages) with a completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and a key...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,227.26 to AmerisourceBergen Drug Corp for the supply of Verquvo 10 mg tablets (30-count packaging). The award, made on July 8, 2025, with an ultimate completion date of July 9, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $9,021.18 to AmerisourceBergen Drug Corp for VERQUVO 5 mg tablets (30-count supply) under a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by October 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,721.73 to AmerisourceBergen Drug Corp for Verquvo 5 mg tablets (14-count packaging) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this requirement as...